The FDA schedules its proposed rule for April 2024
In 2022, the Journal of the National Cancer Institute (JNCI) found that regularly using chemical hair relaxers could more than double a woman’s risk of developing uterine cancer. One year later, the Black Women’s Health Study at Boston University published its own research linking hair relaxers to an increased risk of uterine cancer.
Then in October 2023, the Food and Drug Administration revealed that it would propose a ban on all hair relaxers sold in the U.S. that contained formaldehyde-releasing chemicals by April 2024. According to the FDA’s proposed rule abstract—which has not been finalized—the agency has been receiving inquiries from consumers and salon professionals about the safety of hair relaxers containing formaldehyde since the late 2000s.
The FDA delays its ban proposal… again and again
Not satisfied with the agency’s sudden lack of action, three U.S. House Representatives sent a letter in August demanding that the FDA explain why the proposal was delayed for so long. The FDA did not publicly respond to the House members’ inquiry, and the agency once again failed to release its proposed rule by its September 2024 deadline.
So will hair relaxers with formaldehyde ever be banned?
Though it’s likely that the proposed rule will be pushed back again in March, the FDA will have a hard time remaining silent as legal pressure continues to grow against dozens of hair relaxer brands. As of January 2025, over 10,000 women have sued major beauty companies like L’Oreal and Revlon with claims that using hair relaxers caused them to develop uterine cancer.
How to join the hair relaxer lawsuit
If you recently developed uterine cancer, you may be eligible to join the lawsuit and help pressure the FDA to finally take action against the use of formaldehyde in hair relaxers. Take our quick 60-second hair relaxer evaluation to see if you may be eligible for a settlement.